← Leaderboards
Catalina Lee Chang
Northwestern University At Chicago
$2,727,429
Attributed
$2,727,429
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $678K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,727,429 · 2
By mechanism
R37$1,802,094 · 1
P50$925,335 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Zhuoli Zhang$4,626,286
- Dong-Hyun Kim$8,303,552
- Crismita Clement Dmello$800,000
- Gurvinder Kaur$59,166
Others in their field
Other Emerging Leaders on “Ensure”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$142,551,806
Research focus
EnsureGlioblastomaCytokineDesignCd86 GeneCellular ImmunityCharacteristicsCross PresentationCellsCytotoxicityAntibodiesAntigensB-Cell ActivationAnti-Pd-L1AnimalsCd8-Positive T-LymphocytesClinicCostAntigen PresentationB-LymphocytesCell TherapyCancer ImmunotherapeuticsAutologousGlioma
Grant awards (8)
Development of B-cell-based vaccine for Glioblastoma$366,000
R37 · FY2025 · CA · contact PI
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas$311,960
P50 · FY2025 · CA · contact PI
Development of B-cell-based vaccine for Glioblastoma$347,701
R37 · FY2024 · CA · contact PI
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas$311,543
P50 · FY2024 · CA · contact PI
Development of B-cell-based vaccine for Glioblastoma$358,680
R37 · FY2023 · CA · contact PI
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas$301,832
P50 · FY2023 · CA · contact PI
Development of B-cell-based vaccine for Glioblastoma$366,000
R37 · FY2022 · CA · contact PI
Development of B-cell-based vaccine for Glioblastoma$363,713
R37 · FY2021 · CA · contact PI